Company

About Sorin Group USA, Inc.
There are but a handful of companies throughout the world sufficiently qualified to design and manufacture cardiac perfusion and blood management systems. Within this exclusive group, only one company has focused the entirety of its resources on the advancement of perfusion and blood management: Sorin Group USA, Inc..

As the U.S. division of Sorin Group, a global company listed on the Milan stock exchange (SORN.MI), Sorin Group USA, Inc. provides much more than quality systems, devices and disposables. We provide the education, innovation and leadership so vital to cardiovascular industry advancement.

As the field of cardiac surgery evolves, we are committed to a future where the needs of the patient, the surgical team and the hospital’s bottom line are fully served.

Fast facts about Sorin Group

• More than four decades of technological innovation and manufacturing expertise
• Over 3,500 team members globally
• More than 450 people dedicated to R&D across Europe and North America
• Portfolio of 2,195 patents
• Listed on the Milan Stock Exchange

For more information about our parent company, please visit www.sorin.com.